Capsugel plans to up micronisation capacity at Quakertown, Pennsylvania facility to provide API processing services for clinical candidates and commercial drugs.
Rumoured IPO-ready Capsugel has added micro-dose capabilities at its facility in Ploërmel, France citing its acquisition of Xcelience as the driver for the expansion.
Pharmaceutical giant Pfizer has agreed to sell Capsugel, its drug delivery technology unit, to US investment group Kohlberg Kravis Roberts & Co (KKR) for $2.4bn (€1.7bn).
VWR's parent company has signed a definitive agreement to sell the
world's second largest laboratory supplier after its recent period
of significant growth and profitability.
Finland's Kemira has completed the divestment of its fine chemicals
business, which now operates as KemFine under the control of the
division's former management team.
Finnish chemicals group Kemira has agreed to sell off its fine
chemicals business to a private equity firm, exiting from what it
sees as a non-core sector, reports Phil Taylor.
A US-based private equity firm is the latest to join the list of
bidders for Dynamit Nobel, the chemicals business being sold by
German chemicals and engineering group MG Technologies.
